Kathmandu, Dec 20: The Department of Drug Administration (DDA) has banned 10 types of medicines in Nepal. Issuing a notice, the ban is based on the technical evaluation of the drugs, it said. The banned medicines are produced in Nepal and neighbouring India.
The banned medicines include linagliptin (2.5 mg), linagliptin (10 mg), rivaroxaban (5 mg), aceclofenac (200 mg), aceclofenac (300 mg), metformin (500 mg), metformin (850 mg), and linagliptin (5 mg).
